Dr. Kathryn M. Leininger
Claim this profileCleveland Clinic Akron General
Area of expertise
Lung Cancer
Kathryn M. Leininger has run 6 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Kathryn M. Leininger has run 4 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Cleveland Clinic Akron General
Clinical Trials Kathryn M. Leininger is currently running
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting
1 award
N/A
9 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Kathryn M. Leininger
Clinical Trial Related
5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Kathryn M. Leininger has experience with
- Biospecimen Collection
- Oxaliplatin
- Fluorouracil
- Questionnaire Administration
- Paclitaxel
- Pembrolizumab
Breakdown of trials Kathryn M. Leininger has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn M. Leininger specialize in?
Kathryn M. Leininger focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Kathryn M. Leininger currently recruiting for clinical trials?
Yes, Kathryn M. Leininger is currently recruiting for 5 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Kathryn M. Leininger has studied deeply?
Yes, Kathryn M. Leininger has studied treatments such as Biospecimen Collection, Oxaliplatin, Fluorouracil.
What is the best way to schedule an appointment with Kathryn M. Leininger?
Apply for one of the trials that Kathryn M. Leininger is conducting.
What is the office address of Kathryn M. Leininger?
The office of Kathryn M. Leininger is located at: Cleveland Clinic Akron General, Akron, Ohio 44307 United States. This is the address for their practice at the Cleveland Clinic Akron General.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.